Peptide-Based Metabolic Disorder Therapeutics Market to Reach US$ 77.9 Billion by 2033 with 12% CAGR
The market for peptide-based metabolic disorder therapeutics is expected to experience significant growth, with a remarkable compound annual growth rate (CAGR) of 12% from 2023 …